Syros Pharmaceuticals Inc (SYRS)
5.13
-0.07
(-1.35%)
USD |
NASDAQ |
May 03, 16:00
5.13
0.00 (0.00%)
After-Hours: 20:00
Syros Pharmaceuticals Cash and Short Term Investments (Quarterly): 139.53M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 139.53M |
| September 30, 2023 | 112.22M |
| June 30, 2023 | 143.98M |
| March 31, 2023 | 165.80M |
| December 31, 2022 | 202.30M |
| September 30, 2022 | 244.48M |
| June 30, 2022 | 86.28M |
| March 31, 2022 | 110.26M |
| December 31, 2021 | 130.37M |
| September 30, 2021 | 145.58M |
| June 30, 2021 | 182.03M |
| March 31, 2021 | 222.14M |
| December 31, 2020 | 173.98M |
| September 30, 2020 | 93.13M |
| June 30, 2020 | 108.67M |
| March 31, 2020 | 121.88M |
| December 31, 2019 | 91.42M |
| Date | Value |
|---|---|
| September 30, 2019 | 108.14M |
| June 30, 2019 | 121.72M |
| March 31, 2019 | 75.87M |
| December 31, 2018 | 99.68M |
| September 30, 2018 | 113.23M |
| June 30, 2018 | 124.37M |
| March 31, 2018 | 121.74M |
| December 31, 2017 | 72.05M |
| September 30, 2017 | 81.95M |
| June 30, 2017 | 91.52M |
| March 31, 2017 | 70.49M |
| December 31, 2016 | 83.59M |
| September 30, 2016 | 93.49M |
| June 30, 2016 | 50.12M |
| March 31, 2016 | 62.13M |
| December 31, 2015 | 35.91M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
86.28M
Minimum
Jun 2022
244.48M
Maximum
Sep 2022
142.31M
Average
130.37M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| PDS Biotechnology Corp | 56.56M |
| PAVmed Inc | 19.64M |
| Moderna Inc | 8.523B |
| Altimmune Inc | 197.82M |
| iBio Inc | 2.788M |